Cargando…

Roseburia intestinalis inhibits interleukin-17 excretion and promotes regulatory T cells differentiation in colitis

Roseburia intestinalis (R. intestinalis) is one of the dominant intestinal bacterial microbiota and is decreased in patients with inflammatory bowel disease (IBD). It helps protect colonic mucosa against the development of inflammation and subsequent IBD, however its underlying mechanisms are unclea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Changxin, Song, Kerui, Shen, Zhaohua, Quan, Yongsheng, Tan, Bei, Luo, Weiwei, Wu, Shuai, Tang, Kai, Yang, Zhenyu, Wang, Xiaoyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983956/ https://www.ncbi.nlm.nih.gov/pubmed/29620246 http://dx.doi.org/10.3892/mmr.2018.8833

Ejemplares similares

Roseburia intestinalis supernatant ameliorates colitis induced in mice by regulating the immune response
por: Luo, Weiwei, et al.
Publicado: (2019)

Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species
por: Nie, Kai, et al.
Publicado: (2021)

Roseburia intestinalis stimulates TLR5-dependent intestinal immunity against Crohn's disease
por: Shen, Zhaohua, et al.
Publicado: (2022)

Roseburia intestinalis-derived flagellin ameliorates colitis by targeting miR-223-3p-mediated activation of NLRP3 inflammasome and pyroptosis
por: Wu, Xing, et al.
Publicado: (2020)

Assessment of the safety and probiotic properties of Roseburia intestinalis: A potential “Next Generation Probiotic”
por: Zhang, Chao, et al.
Publicado: (2022)

New pathway ameliorating ulcerative colitis: focus on Roseburia intestinalis and the gut–brain axis
por: Xu, Fenghua, et al.
Publicado: (2021)

Roseburia intestinalis and Its Metabolite Butyrate Inhibit Colitis and Upregulate TLR5 through the SP3 Signaling Pathway
por: Ruan, Guangcong, et al.
Publicado: (2022)

Interactions between Roseburia intestinalis and diet modulate atherogenesis in a murine model
por: Kasahara, Kazuyuki, et al.
Publicado: (2018)

The human gut Firmicute Roseburia intestinalis is a primary degrader of dietary β-mannans
por: La Rosa, Sabina Leanti, et al.
Publicado: (2019)

Starvation responses impact interaction dynamics of human gut bacteria Bacteroides thetaiotaomicron and Roseburia intestinalis
por: Liu, Bin, et al.
Publicado: (2023)

Roseburia intestinalis Modulates PYY Expression in a New a Multicellular Model including Enteroendocrine Cells
por: Gautier, Thomas, et al.
Publicado: (2022)

Roseburia intestinalis relieves intrahepatic cholestasis of pregnancy through bile acid/FXR-FGF15 in rats
por: Sun, Hanxiang, et al.
Publicado: (2023)

Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8(+) T cells
por: Kang, Xing, et al.
Publicado: (2023)

A Polyclonal Aptamer Library for the Specific Binding of the Gut Bacterium Roseburia intestinalis in Mixtures with Other Gut Microbiome Bacteria and Human Stool Samples
por: Xing, Hu, et al.
Publicado: (2022)

Th17 cells in primary Sjögren’s syndrome negatively correlate with increased Roseburia and Coprococcus
por: Xin, Xiaohong, et al.
Publicado: (2022)

Complete Genome Sequence of the Human Gut Symbiont Roseburia hominis
por: Travis, Anthony J., et al.
Publicado: (2015)

Human Gut Symbiont Roseburia hominis Promotes and Regulates Innate Immunity
por: Patterson, Angela M., et al.
Publicado: (2017)

Roseburia Abundance Associates With Severity, Evolution and Outcome of Acute Ischemic Stroke
por: Gu, Mengmeng, et al.
Publicado: (2021)

Functional Phenotypes of Peritoneal Macrophages Upon AMD3100 Treatment During Colitis-Associated Tumorigenesis
por: Wu, Shuai, et al.
Publicado: (2022)

Butyryl-CoA:acetate CoA-transferase gene associated with the genus Roseburia is decreased in the gut microbiota of Japanese patients with ulcerative colitis
por: SHINOHARA, Ryohei, et al.
Publicado: (2019)

Cytokine Expression of Microscopic Colitis Including Interleukin-17
por: Park, Eunkyoung, et al.
Publicado: (2015)

The presence of Giardia intestinalis in donkeys, Equus asinus, in China
por: Zhang, Xiao-Xuan, et al.
Publicado: (2017)

Roseburia hominis Increases Intestinal Melatonin Level by Activating p-CREB-AANAT Pathway
por: Song, Lijin, et al.
Publicado: (2021)

Study of Cis-regulatory Elements in the Ascidian Ciona intestinalis
por: Irvine, Steven Q
Publicado: (2013)

Pneumatosis intestinalis caused by Cryptosporidium colitis in a non-immunocompromised patient
por: Tang, Wesley, et al.
Publicado: (2021)

miR‐126 downregulates CXCL12 expression in intestinal epithelial cells to suppress the recruitment and function of macrophages and tumorigenesis in a murine model of colitis‐associated colorectal cancer
por: Wu, Shuai, et al.
Publicado: (2022)

Faecalibacterium prausnitzii Inhibits Interleukin-17 to Ameliorate Colorectal Colitis in Rats
por: Zhang, Mingming, et al.
Publicado: (2014)

Roseburia hominis Alleviates Neuroinflammation via Short‐Chain Fatty Acids through Histone Deacetylase Inhibition
por: Song, Lijin, et al.
Publicado: (2022)

Effect of Cortisone on 17-Ketosteroid Excretion
por: Sokal, Joseph E., et al.
Publicado: (1954)

Pneumatosis Intestinalis
por: Awashima, Maiko, et al.
Publicado: (2018)

Pneumatosis intestinalis
por: Takemura, Keisuke, et al.
Publicado: (2017)

Interleukin-6-mediated CCR9(+) interleukin-17-producing regulatory T cells polarization increases the severity of necrotizing enterocolitis
por: Ma, Fei, et al.
Publicado: (2019)

Butyrate inhibits interleukin-17 and generates Tregs to ameliorate colorectal colitis in rats
por: Zhang, Mingming, et al.
Publicado: (2016)

Prebiotic Effects of Wheat Arabinoxylan Related to the Increase in Bifidobacteria, Roseburia and Bacteroides/Prevotella in Diet-Induced Obese Mice
por: Neyrinck, Audrey M., et al.
Publicado: (2011)

Comparative genomics of the genus Roseburia reveals divergent biosynthetic pathways that may influence colonic competition among species
por: Hillman, Ethan T., et al.
Publicado: (2020)

Interleukin-23 Restrains Regulatory T Cell Activity to Drive T Cell-Dependent Colitis
por: Izcue, Ana, et al.
Publicado: (2008)

Modulation of autoimmune diseases by interleukin (IL)-17 producing regulatory T helper (Th17) cells
por: Singh, Bhagirath, et al.
Publicado: (2013)

Pneumatosis cystoides intestinalis
por: Yamamoto, Shunsuke, et al.
Publicado: (2020)

Remarks on the Tractus Intestinalis
por: Robinson, Byron
Publicado: (1903)

Targeting interleukin-17 receptors
por: Lee, Wen-Hwa, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cqmakdtlui66385o0vh203ccl1